Gain insight into how the industry addresses regulatory and business challenges and embraces new and exciting technology in an ever-evolving health policy landscape. New this year, a unique partnering experience to connect with key players in the industry.

Industry innovators, lawmakers and leading regulators will provide in-depth analysis, thoughtful guidance and strategic insights on:

• Local and national coverage for the molecular testing marketplace, featuring both Centers for Medicare & Medicaid Services (CMS) leadership and Medicare Administrative Contractors (MACs) from MolDX and Novitas

• Food and Drug Administration (FDA) oversight of diagnostic testing, including laboratory-developed tests

• Fraud and abuse trends in diagnostic testing arrangements

• Private payer positioning and evidence for diagnostic testing

• The new administration’s focus on the scientific and research community to accelerate vaccines, therapies and diagnostics